Dienogest inhibits Toll-like receptor 4 expression induced by costimulation of lipopolysaccharide and high-mobility group box 1 in endometrial epithelial cells
Dienogest was found to inhibit the expression of Toll-like receptor 4, which was induced by the combined stimulation of lipopolysaccharide and high-mobility group box 1 in endometrial epithelial cells.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (28)
- Dienogest via openalex
- Dienogest, a synthetic progestin, inhibits prostaglandin E2 production and aromatase expression by human endometrial epithelial cells in a spheroid culture system via openalex
- Dienogest, a synthetic progestin, inhibits the proliferation of immortalized human endometrial epithelial cells with suppression of cyclin D1 gene expression via openalex
- Dienogest inhibits BrdU uptake with G0/G1 arrest in cultured endometriotic stromal cells via openalex
- Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis—a randomized, double-blind, multicenter, controlled trial via openalex
- Distinct mechanisms regulate cyclooxygenase-1 and -2 in peritoneal macrophages of women with and without endometriosis via openalex
- Escherichia coli contamination of menstrual blood and effect of bacterial endotoxin on endometriosis via openalex
- Estrogen Receptor-β, Estrogen Receptor-α, and Progesterone Resistance in Endometriosis via openalex
- Progesterone and progestational compounds attenuate tumor necrosis factor alpha–induced interleukin-8 production via nuclear factor kappaB inactivation in endometriotic stromal cells via openalex
- TLR3 and TLR4 expression in healthy and diseased human endometrium via openalex
- Toll-like receptor 4-mediated growth of endometriosis by human heat-shock protein 70 via openalex
- doi:10.4049/jimmunol.0900390 via openalex
- doi:10.1111/j.1447-0578.2007.00189.x via openalex
- doi:10.1016/j.cellbi.2007.01.034 via openalex
- doi:10.1089/vim.2010.0080 via openalex
- doi:10.1093/humrep/dep469 via openalex
- doi:10.1210/jc.2004-0241 via openalex
- doi:10.1038/sj.cdd.4401850 via openalex
- doi:10.1111/j.1447-0756.2009.01076.x via openalex
- doi:10.1159/000212061 via openalex
- doi:10.1016/s0002-9440(10)63583-3 via openalex
- doi:10.1016/j.biocel.2009.10.009 via openalex
- doi:10.1152/ajpcell.00401.2005 via openalex
- doi:10.1016/j.smim.2006.12.002 via openalex
- doi:10.1016/j.imlet.2009.07.003 via openalex
- doi:10.1002/art.10540 via openalex
- doi:10.1016/j.molmed.2007.09.002 via openalex
- doi:10.1016/j.jmig.2009.06.017 via openalex
Cited by (20)
- The Therapeutic Role of Dienogest in Endometriosis-Associated Pain: From Basics to Clinics 2026
- Azurocidin is associated with dienogest-resistance in ovarian endometriotic cysts 2024
- DETERMINATION OF IL-1β mRNA GENE EXPRESSION AND HMGB-1 mRNA GENE EXPRESSION IN WOMEN WITH GENITAL ENDOMETRIOSIS ASSOCIATED WITH INFERTILITY AT THE STAGE OF PREPARATION FOR ASSISTED REPRODUCTIVE TECHNOLOGIES 2024
- [Psychoemotional state and sexual function in women with chronic pelvic pain in genital endometriosis] 2024
- Efficacy and Safety of Dienogest in the Management of Women with Endometriosis; Systematic Review and Meta-Analysis 2023
- Pattern-recognition receptors in endometriosis: A narrative review 2023
- The Role of NF-κB in Endometrial Diseases in Humans and Animals: A Review 2023
- Role of estrogen and estrogen-related factors in endometriosis 2021
- Systematic review and Meta-analysis of efficacy and safety of dienogest in treatment of endometriosis 2021
- The effectiveness of therapy for endometriosis-associated pelvic pain resistant to surgical treatment 2021
- Long-term treatment of endometriosis with dienogest: retrospective analysis of efficacy and safety in clinical practice 2018
- Aromatase as a target for treating endometriosis 2018
- Investigational Medical Therapies for Endometriosis: Current Data and Future Trends 2017
- Dienogest for Treatment of Endometriosis in Chinese Women: A Placebo-Controlled, Randomized, Double-Blind Phase 3 Study 2017
- High Expression of High-Mobility Group Box 1 in Menstrual Blood: Implications for Endometriosis 2017
- Dienogest reduces HSD17β1 expression and activity in endometriosis 2015
- Does dienogest influence the inflammatory response of endometriotic cells? A systematic review 2015
- Dienogest, a synthetic progestin, down-regulates expression of CYP19A1 and inflammatory and neuroangiogenesis factors through progesterone receptor isoforms A and B in endometriotic cells 2014
- Dienogest improves human leucocyte antigen-DR underexpression and reduces tumour necrosis factor-α production in peritoneal fluid cells from women with endometriosis 2014
- Dienogest inhibits nerve growth factor expression induced by tumor necrosis factor-α or interleukin-1β 2013
Source provenance
- openalex
- last seen: 2026-05-14T06:07:48.142452+00:00